London, UK, 23 November 2007. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced the closing of a ?690,000 financing round involving an institutional investor for the first time. The fundraising was comprised of a rights issue in which ?440,000 was raised from a number of founding shareholders, followed by investment of ?250,000 from [...]